As per the latest research report titled ‘Apheresis Equipment Market Size By Product (Disposable Apheresis Kits, Apheresis Machines), By Application (Renal Disease, Neurology, Hematology), By Procedure (Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis), By Technology (Membrane filtration, Centrifugation) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, GCC Countries, Turkey), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’ available with Market Study Report, the global apheresis equipment market is anticipated to surpass US $4.5 billion by the year 2025.
 

Rising prevalence of blood related disorders such as blood cancer, sickle-cell disease, thalassemia, and hemophilia among individuals of different age groups is the key parameter stimulating the growth of apheresis equipment. Individuals suffering from blood related ailments encounter blood clotting issues and hence fuel the demand for blood components. Surging demand for plasma and other blood component will favor the adoption of apheresis equipment across the globe.
 

Favorable regulatory framework encouraging the production of plasma derived and blood derived medicinal products, along with numerous initiatives undertaken to ensure quality and safety of blood components during collection, processing, storage, and distribution will embolden the market outlook. However, rising concern regarding the shelf-life of blood components is presumed to hamper the growth of apheresis equipment market in the upcoming years.
 

Based on the product terrain, apheresis machines market segment held 30% revenue share in 2018 and will continue to display similar growth trends over the analysis period, cites the report. These machines efficiently separate various blood components and are durable, hence are widely used for transfusion treatment.
 

Speaking of the application spectrum, apheresis equipment market from hematology segment was worth US $795 million in 2018. Surging use of HAU (hematology apheresis unit) for analysis of blood components and marrow having stem cell peripheral blood assemblies will drive the segmental growth.
 

In terms of the type of procedure, plasmapheresis segment is predicted to accrue US $2.2 billion by the year 2025, as this process is used for removing plasma from patient’s blood. The technique is applied for treating autoimmune diseases, wherein, blood components are replaced with appropriate intravenous fluid.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/467861/
 

Considering the technology outlook, membrane filtration segment is expected to grow with a CAGR of 10% during 2019-2025, owing to its flexibility of functioning effectively at low temperatures. Growing demand of plasma and platelets for treating various blood-related diseases will boost the adopting of membrane filtration technology.
 

Elaborating on the geographical landscape, North America apheresis equipment market held over 40% revenue share in 2018 and is estimated to witness significant growth through 2025. The regional growth is credited to advanced healthcare infrastructure and increasing healthcare expenditure.

The key players operating in apheresis equipment market include Fresenius, Hemacare, Therakos, Asahi Kasei Kuraray Medical, B. Braun, Kawasumi Laboratories, Fenwal, Terumo BCT, and Haemonetics among others.